 |
5 Diseases |  |
1 Trial |
|
1 Trial |  |
133 News |  |
| «12 |
- NeuVax (nelipepimut-S) / Dr. Reddy's
Trial initiation date: Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=100, Completed, Sponsor: COL George Peoples, MD, FACS
Initiation date: May 2000 --> Jul 2001
- NeuVax (nelipepimut-S) / Dr. Reddy's
Trial completion: Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=95, Completed, Sponsor: COL George Peoples, MD, FACS
Initiation date: May 2000 --> Jul 2001 Active, not recruiting --> Completed
- NeuVax (nelipepimut-S) / Dr. Reddy's
Trial completion: Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=100, Completed, Sponsor: COL George Peoples, MD, FACS
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| NeuVax (nelipepimut-S) / Dr. Reddy's
Trial primary completion date: PRESENT: Efficacy and Safety Study of NeuVax (clinicaltrials.gov) - May 27, 2014
P3, N=700, Recruiting, Sponsor: Galena Biopharma, Inc.
Active, not recruiting --> Completed Trial primary completion date: May 2015 --> Jun 2017
- ||| NeuVax (nelipepimut-S) / Dr. Reddy's
Trial completion date: PRESENT: Efficacy and Safety Study of NeuVax (clinicaltrials.gov) - May 27, 2014
P3, N=700, Recruiting, Sponsor: Galena Biopharma, Inc.
Trial primary completion date: May 2015 --> Jun 2017 Trial completion date: May 2022 --> Jun 2024
- Leukine (sargramostim) / Partner Therap, NeuVax (nelipepimut-S) / Dr. Reddy's, Herceptin (trastuzumab) / Roche
Enrollment open: Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax (clinicaltrials.gov) - Feb 13, 2013
P2, N=300, Recruiting, Sponsor: Jarrod P. Holmes, MD, FACP
Trial completion date: May 2022 --> Jun 2024 Not yet recruiting --> Recruiting
- | Leukine (sargramostim) / Partner Therap, NeuVax (nelipepimut-S) / Dr. Reddy's, Herceptin (trastuzumab) / Roche
New P2 trial: Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax (clinicaltrials.gov) - Apr 2, 2012
P2, N=300, Recruiting, Sponsor: Jarrod P. Holmes, MD, FACP
- || NeuVax (nelipepimut-S) / Dr. Reddy's
New P3 trial: PRESENT: Efficacy and Safety Study of NeuVax (clinicaltrials.gov) - Nov 22, 2011
P3, N=700, Recruiting, Sponsor: Galena Biopharma, Inc.
- NeuVax (nelipepimut-S) / Dr. Reddy's
Enrollment closed: Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients (clinicaltrials.gov) - Aug 18, 2011
P1/2, N=100, Active, not recruiting, Sponsor: COL George Peoples, MD, FACS
Not yet recruiting --> Recruiting Completed --> Active, not recruiting